Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 701–800 of 1,000

[New populations at increased cardiovascular risk: Cardiovascular disease in dermatological diseases].
Godoy-Gijon, E., Meseguer-Yebra, C., Palacio-Aller, L., Godoy-Rocati, D., & Lahoz-Rallo, C. (2016) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2015.08.001 · Cited by 1
Women’s Health Considerations for Lipid Management
Wild, R. A., Weedin, E. A., & Gill, E. A. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.005 · Cited by 4
Self-citation
Treatment of polycystic ovarian syndrome in primary care
Graham, A., & Hamoda, H. (2016) · Prescriber · doi:10.1002/psb.1515 · Cited by 4
Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome
Karadağ, C., & Yoldemir, T. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2019.1603213 · Cited by 4
Application of Mushrooms in the Management of Cardiovascular Diseases
Lawal, E. E., Iseghohi, F., Aishat, S. R., Osi, A. R., Oyewole, O. A., Adetunji, C. O., Popoola, O. A., & Israel, A. O. (2025) · doi:10.1002/9781394212699.ch10 · Cited by 4
Association of dietary phytochemical index with metabolic markers, serum asymmetric dimethylarginine and atherogenic indices in patients with polycystic ovary syndrome
Amirkhizi, F., Taghizadeh, M., Hamedi-Shahraki, S., & Asghari, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00932-1 · Cited by 3
“Dyslipidemia is a prevalent metabolic issue in PCOS patients [49], often manifesting in various patterns such as low HDL-C levels, elevated TG, TC, and LDL-C levels [50], potentially influenced by factors like IR, hyperan-drogenism, diet, exercise, and genetics [51].”
Is There a Difference in Anxiety, Body Perception, and Depression Scales According to Subphenotypes of Polycystic Ovary Syndrome?
Canpolat, A. G., Demir, Ö., Sert, M. S., Yarsan, B., Tekfidan, Z., Yaman, Ş. N., Oğuz, E., Gazal, E., Şimşek, H. H., Ensarı, T. A., et al. (2021) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.52244 · Cited by 3
Targeting the root cause of obesity-related comorbidities through weight independent and dependent actions on insulin sensitivity: Benefits of dual amylin and calcitonin receptor agonists
Larsen, A. T., Melander, S. A., Mohamed, K. E., Petersen, E. A., Benmarce, M., Karsdal, M. A., & Henriksen, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118388 · Cited by 3
Cardiovascular Consequences of Premature Menopause
Bast, J. A., Olubi, O. M., Le, D. E., Parashar, S., Dobrescu, I., & Kondapalli, L. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02265-0 · Cited by 3
Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial
Bunyapipat, P., Klangsin, S., Peeyananjarassri, K., Wattanakumtornkul, S., Katesuwan, S., Geater, A. F., & Numit, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70126 · Cited by 3
Lifestyle and diet in PCOS
Capozzi, A., Scambia, G., Driul, L., Vignali, M., & Lello, S. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05746-x · Cited by 8
Decoding polycystic ovary syndrome: an integrated review of epidemiology, molecular mechanisms, animal models, and the expanding therapeutic landscape
Sharata, E. E., Abdel-Samea, A. S., Ibrahim, L. Y., Mamdouh, M., Khalid, N., Rabea, M., Mohamed, G. H., Abdelnaser, M., & Mohyeldin, R. H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05559-4 · Cited by 3
Exogenous estradiol increases cardiovagal baroreflex sensitivity during a hypertensive stimulus in premenopausal young women
Richey, R. E., Miner, J. A., Miner, J. C., Brunt, V. E., Kaplan, P., Halliwill, J. R., & Minson, C. T. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00131.2025 · Cited by 3
Association Between Single Nucleotide Polymorphisms of Sterol Regulatory Element Binding Protein-2 and Liver X Receptor α Gene and Risk of Polycystic Ovary Syndrome in a Chinese Han Population
Zhao, J., Hu, Z., Cai, L., Liu, L., Jiang, X., Wu, L.-Z., & Gong, J. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0075-5 · Cited by 3
Oral contraceptives in polycystic ovarian syndrome: the long and short of it
Nader, S. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.88 · Cited by 3
Incorporating patient preference into the management of infertility in women with polycystic ovary syndrome
Jungheim, E. S., & Okoroafor (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s25286 · Cited by 3
The polycystic ovary syndrome: a position statement from the European Society of
Conway, G. S., Dewailly, D., Diamanti‐Kandarakis, E., Franks, S., Gambineri, A., Keleştimur, F., Μacut, D., Micić, D., Pasquali, R., Pfeifer, M., et al. (2014) · Cited by 3
Self-citation
Polycystic Ovarian Syndrome in Perimenopausal Women: A Pilot Study
Chhabra, S. A., & Taori, A. (2015) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000157 · Cited by 3
Polycystic ovarian syndrome: overdiagnosed and overtreated?
Wilcock, J., & Taylor, D. (2018) · British Journal of General Practice · doi:10.3399/bjgp18x696113 · Cited by 4
Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study
Rashid, A., Masood, A., Wani, I. A., Hafeez, I., Parvez, T., Zargar, M. A., & Ganie, M. A. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.02.001 · Cited by 3
Polycystic Ovary Syndrome
Nasseh, A., & Sarvaideo, J. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_6 · Cited by 3
A Literature Review of the Effects of PCOS on Cardiovascular Health
Mundle, K., & Raza, Z. (2021) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.238 · Cited by 3
An Occult Leydig Cell Tumour in a Postmenopausal Woman Presenting with Alopecia and Hirsutism: A Case Report
Shwana, S., Shrikrishnapalasuriyar, N., Yin, W. L., Vij, M., & Kalhan, A. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.75 · Cited by 3
Polycystic ovarian syndrome with endometrial hyperplasia and uterine fibroids treated with homoeopathy: A case report
Shinde, V. (2022) · Indian Journal of Research in Homoeopathy · doi:10.53945/2320-7094.1067 · Cited by 3
Prediction of metabolic syndrome by visceral adiposity index, lipid accumulation product and model of adiposity index amongst infertile women with and without polycystic ovary syndrome
Saxena, P., Gaur, J., Mishra, A., & Jain, A. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20230540 · Cited by 3
Serum steroid profile captures metabolic phenotypes in adults with classic congenital adrenal hyperplasia
Ahn, C. H., Shim, J., Jang, H. N., Lee, Y. A., Lee, S., Choi, M. H., & Kim, J. H. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106374 · Cited by 3
Metabolic dysfunctions in polycystic ovary syndrome
Rahman, M., Rahman, F. T., Mallik, M. U., Saha, J., Rahman, M. M., & Azad, K. A. K. (2024) · Journal of Medicine · doi:10.3329/jom.v25i1.70703 · Cited by 7
Placental mRNA Expression of Neurokinin B Is Increased in PCOS Pregnancies with Female Offspring
Markantes, G. Κ., Panagodimou, E., Koika, V., Mamali, I., Kaponis, A. I., Adonakis, G. L., & Georgopoulos, N. A. (2024) · Biomedicines · doi:10.3390/biomedicines12020334 · Cited by 2
AI-Driven Hormonal Profiling: A Game-Changer in Polycystic Ovary Syndrome Prevention
Tsaliki, K. (2024) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2024.61001 · Cited by 3
The hyperemic response to exercise is blunted in females with polycystic ovary syndrome
Huckins, W., Delage, S. I., Berbrier, D. E., Skolnik, D. A., Keightley, H. S. A., & Usselman, C. W. (2025) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00263.2024 · Cited by 3
Understanding Dyslipidemia in Women across their Lifespan: Sex Differences in Lipoprotein Metabolism and Hormonal Influence
Mahilmaran, A., Chigullapalli, S., Parwani, P. J., Sharma, P., Senguttuvan, N. B., & Nayak, R. (2025) · Indian Journal of Cardiovascular Disease in Women · doi:10.25259/ijcdw_70_2025 · Cited by 3
Complementary Therapy with Traditional Chinese Medicine for Polycystic Ovarian Syndrome
Liao, Y.-N., Hu, W.-L., & Hung, Y. (2018) · InTech eBooks · doi:10.5772/intechopen.71654 · Cited by 4
Cross-sex hormonal replacement: is this really effective? an experimental clue
Pavón, N., Pérez-Torres, I., Aranda‐Fraustro, A., Roldán, F., Paredes, C., & Chávez, E. (2013) · Endocrine · doi:10.1007/s12020-013-9905-2 · Cited by 3
The link between polycystic ovary syndrome and Type 2 diabetes: what do we know today?
Sathyapalan, T., & Atkin, S. L. (2011) · Diabetes Management · doi:10.2217/dmt.11.59 · Cited by 3
An Exploratory Survey To Assess The Knowledge, Practice And Prevalence Of Polycystic Ovarian Syndrome Among Women Attending Gyne OPD Of Selected Hospital Of Delhi With A View To Develop A Health Care Package On Polycystic Ovarian Syndrome And Its Management
Dalal, M., Babu, M., & Rastogi, D. M. S. (2014) · IOSR Journal of Nursing and health Science · doi:10.9790/1959-03643942 · Cited by 3
Caring for women with polycystic ovary syndrome
Pereira, K. C., & Kreider, K. E. (2016) · The Nurse Practitioner · doi:10.1097/01.npr.0000480586.24537.64 · Cited by 3
STUDY OF GLYCATED HEMOGLOBIN LEVELS IN POLYCYSTIC OVARY SYNDROME
Renuka, P., Shakthiya, T., & Vm, V. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i5.22729 · Cited by 4
PCOS Therapy
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_6 · Cited by 3
Interleukin 10 (IL-10) gene variants and haplotypes in Tunisian women with polycystic ovary syndrome (PCOS): a case-control study
Salem, A. B., Ezzidi, I., Abdennebi, H. B., Mahjoub, T., Sarray, S., & Mtiraoui, N. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08706-9 · Cited by 3
Polycystic Ovary Syndrome
Sattar, N. A. (2011) · doi:10.1002/9781444347319.ch16 · Cited by 3
IDO Inhibition by 1-Methyltryptophan: Unlocking New Paths to Treat Ovarian Dysfunction and Hormonal Imbalance in PCOS
Gheymoumi, H., Shayesteh, S., Amiri-Andebili, M., Gheymoumi, N., Sharifi, F., & Dehpour, A. R. (2025) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-164861 · Cited by 2
Mechanistic insights into cholesterol–bile acid metabolic dysregulation in ovarian aging
Yang, Z., Qi, X., & Qiao, J. (2026) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/csb-2025-5865 · Cited by 2
Choroidal vascularization in polycystic ovary syndrome: an optical coherence tomography study
İçöz, M., Golgelioglu, M., & Erkan, E. (2026) · International Ophthalmology · doi:10.1007/s10792-026-03957-4 · Cited by 2
Mid-pregnancy serum chemerin levels predict persistence of postpartum hypertension in patients with polycystic ovary syndrome
Palomba, S., Seminara, G., Costanzi, F., Cannarella, R., Russo, T., Sarica, M., Signore, F., Caserta, D., Calogero, A. E., & Aversa, A. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag102 · Cited by 2
Polycystic Ovary Syndrome and Increased Soluble Tumor Necrosis Factor Like Weak Inducer of Apoptosis Levels Are Independent Predictors of Dyslipidemia in Youth
Erkenekli, K., Öztaş, E., Kuscu, E. N., Keskin, U., Kurt, Y. G., Taş, A., & Yılmaz, N. (2016) · Gynecologic and Obstetric Investigation · doi:10.1159/000447590 · Cited by 2
Venciendo al síndrome del ovario poliquístico con intervenciones en el estilo de vida
Ruiz‐García, A. (2022) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2022.01.003 · Cited by 2
Evaluation of CAG repeat length in the androgen receptor gene and polycystic ovary syndrome risk in Iranian women: A case-control study
Arasteh, H., Araste, F., Sheikhha, M. H., Kalantar, S. M., Yazd, E. F., Ashrafzadeh, H. R., & Ghasemi, N. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i3.10711 · Cited by 2
The Long-Term Health Consequences of Polycystic Ovary Syndrome
Owens, L. A., & Franks, S. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108989831.018 · Cited by 2
Roles of C-Peptide and Triglyceride as Effective Indices for Insulin Resistance Investigations in Iraqi Women with Polycystic Ovarian Syndrome
Al-Murshedi, H. H., Al-Tu’ma, F. J., Hadi, E. A., Mohammed, B. M., & Al-Kayat, T. (2022) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v8i3.1220 · Cited by 2
Polycystic ovary syndrome and metabolic syndrome: Risks in later life
Sheikh, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00019-0 · Cited by 2
Endocrine Disruption in Women: A Cause of PCOS, Early Puberty, or Endometriosis
Wenger, J. M., & Marci, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-36494-5_5 · Cited by 3
Elucidating the Molecular Genetics of Genes CYP19A1, CYP17, and FSHR Variants Association in Polycystic Ovarian Syndrome
Bashir, K., Anum, A., Idrees, I., & Manzoor, H. T. (2024) · Russian Journal of Genetics · doi:10.1134/s1022795424030049 · Cited by 2
Impaired glucose tolerance and insulin resistance in a prenatally‐androgenized rat model of polycystic ovary syndrome in later life
Farhadi‐Azar, M., Noroozzadeh, M., Mousavi, M. A., Naz, M. S. G., & Tehrani, F. R. (2024) · Experimental Physiology · doi:10.1113/ep091912 · Cited by 2
Ranges of Body Mass Index in Polycystic Ovary Syndrome: Maximum and Minimum
Ali, M., & Shah, S. Z. A. (2024) · medtigo Journal of Medicine · doi:10.63096/medtigo30622438 · Cited by 2
Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome—A Late, but Wise Decision
de Sá, M. F. S. (2019) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0039-1685482 · Cited by 3
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2013) · Humana Press eBooks · doi:10.1007/978-1-60761-395-4_25 · Cited by 2
Infertility in women with polycystic ovary syndrome and the role of metformin in management
Boyle, J. A., Teede, H. J., & Misso, M. L. (2013) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.2013.842689 · Cited by 2
Reproduction and Metabolism: Insights from Polycystic Ovary Syndrome
Jasti, P., & Dunaif, A. E. (2012) · Endocrinology and Metabolism · doi:10.3803/enm.2012.27.3.180 · Cited by 2
Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome
Takahashi, T., Igarashi, H., Hara, S., Amita, M., Matsuo, K., Hasegawa, A., & Kurachi, H. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-74 · Cited by 2
For what reasons should metformin be used in the management of polycystic ovary syndrome?
Moghetti, P. (2012) · PubMed · doi:10.3275/8195 · Cited by 2
EIGHT-WEEK AEROBIC TRAINING IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: EFFECTS ON CHRONIC LOW-GRADE INFLAMMATION AND LIPID PROFILES
Saremi, A., & Kazemi, M. R. (2014) · Bimonthly Journal of Hormozgan University of Medical Sciences · Cited by 2
Validation of the obese Ossabaw miniature pig as a model of the obese polycystic ovary syndrome phenotype with concomitant metabolic syndrome: Exploration of polycystic ovary syndrome pathophysiology using in vivo and in vitro models
Newell-Fugate, A. E. (2012) · Cited by 2
Metabolic evaluation and measurement of ovarian volume in polycystic ovary sydrome: a cross-sectional observational study
Evran, M., Ballı, H. T., Sert, M., & Tetiker, B. T. (2016) · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi) · doi:10.17826/cutf.147169 · Cited by 2
Hyperandrogenism: Acne and Hirsutism
Evans, M. B., & Hill, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_40 · Cited by 2
Диагностика и лечение синдрома поликистозных яичников: клиническое практическое руководство общества эндокринологов США, 2013
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2014) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2014.20.22-35 · Cited by 2
Polycystic Ovary Syndrome and Cardiovascular Disease: An Enigmatic Relationship
Mukherjee, S. (2017) · Global Journal of Reproductive Medicine · doi:10.19080/gjorm.2017.01.555571 · Cited by 2
Menstrual Disorders and Hyperandrogenism in Adolescence
DiVall, S. A., & Rosenfield, R. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-73782-9_28 · Cited by 2
Polycystic Ovarian Syndrome
Christou, M., Mintziori, G., Goulis, D. G., & Tarlatzis, B. C. (2023) · ISGE series · doi:10.1007/978-3-031-22378-5_8 · Cited by 2
Long-Term Morbidity: Cardiovascular Disease, Cancer, and Depression in PCOS
Milman, L. W., & Dokras, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_18 · Cited by 2
Self-citation
Metabolic syndrome in patients with the polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., & Papadakis, E. P. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.853451 · Cited by 2
Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome
Otta, C. F., de Mereshian, P. S., Kaplan, R., Iraci, G. S., Ojeda, S., Ochoa, J., Albrecht, A., Filipone, N., & de Cúneo, M. F. (2012) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2012.24019 · Cited by 2
Polycystic ovary syndrome - A challenge of the modern times
Jain, D. (2016) · Maternal and Pediatric Nutrition · doi:10.4172/2472-1182.1000116 · Cited by 2
Association of Perforin and Granzyme-B Levels with Hyperandrogenism in Polycystic Ovary Syndrome: A Case-Control Study
Zarei, E., Shahrebabaki, H. M., Aliakbari, F., Zadeh, F. M., Veghari, G., & Mansourian, A. R. (2019) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2019.393.399 · Cited by 2
Actions of androgens and estrogens in experimental models of cardiovascular disease
Fagman, J. B. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Defining exercise prescription in lifestyle modification programs for overweight/obese polycystic ovary syndrome women
Costa, E. C., & Azevedo, G. D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.037 · Cited by 2
Evaluation of Macular Thickness, Choroidal Thickness, and Choroidal Vascular Index in Patients with Polycystic Ovary Syndrome: An Observational StudyPreprint
Güneş, A., & Gülücü, S. (2025) · Research Square · doi:10.21203/rs.3.rs-6309404/v1 · Cited by 2
Treatment of polycystic ovary syndrome: recent trial results
Ganie, M. A., Chakraborty, S., & Rehman, H. (2015) · Clinical Investigation · doi:10.4155/cli.14.133 · Cited by 1
Elucidating the roles of naturally occurring silent mutations in Polycystic Ovary Syndrome (PCOS)
Gümüşgül, M. D., Şahin, Ş., Turan, H., Karaca, B. T., & Kutlu, A. (2020) · Meta Gene · doi:10.1016/j.mgene.2020.100707 · Cited by 1
Evaluation of Cardiovascular Diseases Risk in the Iranian Population
Akhlaghdoust, M., Pirani, D., Nasiri, M., Ahangarani, S. L., Haghsetan, N., Karbalaiea, M., & Davoodi, P. (2021) · Precision Medicine and Clinical OMICS · doi:10.5812/pmco.121308 · Cited by 1
Clinical manifestations of polycystic ovary syndrome: a modern view
Sosnova, E. A., Gracheva, T. S., & Pesegova, S. V. (2022) · V F Snegirev Archives of Obstetrics and Gynecology · doi:10.17816/2313-8726-2022-9-1-23-31 · Cited by 1
The ovarian immune pathology and reproductive failures
Wu, L., Fang, X., Wang, Y., & Kwak-Kim, J. Y.-H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00018-3 · Cited by 1
The Role of Lipid Accumulation Product (LAP) as a Metabolic Indicator in Polycystic Ovary Syndrome (PCOS)
Prokopakis, I., Pergialiotis, V., Sapantzoglou, I., Zachariou, E., Koutras, A., Thomakos, N., & Pappa, K. I. (2023) · Hellenic Journal of Obstetrics and Gynecology · doi:10.33574/hjog.0531 · Cited by 1
Prevalence, Risk Factors and Management of Polycystic Ovary Syndrome: A Review with Current Evidence
Memon, S. I., Shakeel, M., Syed, H., Amin, K., Khalil, A. A., & Sulaiman, M. (2024) · Iraq Medical Journal · doi:10.22317/imj.v8i1.1268 · Cited by 1
SÍNDROME DOS OVÁRIOS POLICÍSTICOS E SAÚDE MENTAL: UMA REVISÃO SOBRE O IMPACTO PSICOLÓGICO E TRANSTORNOS ASSOCIADOS
Agnol, T. L. D., Hoffmann, K. R. S. S., Batista, L. P. S., Castelo, J. A. Y., Marino, I. E., Alves, S. C. D. O., Mello, G. V. D. C., Latavanha, M. C., Rezende, M. A., & Filho, C. S. A. P. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15485 · Cited by 1
Beneficial Effects of Alchemilla vulgaris in DHEA-Induced Rat Model of Polycystic Ovary Syndrome
Korun, Z. E. U., Göçmez, S. S., Rençber, S. F., Sarıhan, K. K., Eraldemir, F. C., AKPULAT, H. A., Şahin, D., & Yıldız, Ş. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01885-9 · Cited by 3
Exploring 1400 Plasma Metabolites and Polycystic Ovary Syndrome: A Bidirectional Mendelian Randomization Study
Lei, X., Liu, X., Qu, Y., & Huang, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70745 · Cited by 1
Impact of glucose metabolism abnormalities on live birth rate in South-East Asian women with polycystic ovary syndrome
Nguyen, N. T., Ho, V. N. A., Pham, T. D., Nguyen, M. H. N., Nguyen, D. L., Le, L. H., Le, K. T. Q., Ly, L. D., Tran, M. T. N., Ho, T. M., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag012 · Cited by 1
Self-citation
Bridging the Practice Gap: Polycystic Ovary Syndrome as an Under-Recognised Risk State for Ischaemic Stroke and Cardiovascular Disease
Jamshaid, M., Sheikh, A. A., Jamshaid, W., Shafiq, H., & Ahmed, M. H. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15103577 · Cited by 1
From PCOS to PMOS: perspectives on the new nomenclature
Kim, J. J., & Hwang, K. R. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01085-8 · Cited by 1
The Role of Diet and Lifestyle Modification in the Treatment of Polycystic Ovary Syndrome
Thomson, R. L., Teede, H. J., Stepto, N. K., Banting, L., & Moran, L. (2015) · CRC Press eBooks · doi:10.1201/b18190-3 · Cited by 1
Polycystic Ovary Syndrome in Young Women: Issues and Consequences
Norman, R. J., & Moran, L. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360259 · Cited by 1
Self-citation
Ovarian Stromal Tumors: A Rare Cause of Postmenopausal Virilization
Uyking-Naranjo, M., & Mirasol, R. C. (2013) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.028.01.14 · Cited by 1
Comparison of metabolic abnormalities in patients with new-diagnostic polycystic ovary syndrome and with new-diagnostic Type 2 diabetes mellitus
Fang, F., Gu, M., Chen, L., Li, N., Ding, X., & Peng, Y. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.41010 · Cited by 1
Screening for glucose intolerance in polycystic ovary syndrome: hemoglobin A1C, fasting blood glucose or oral glucose tolerance test?
Kelley, C. E., Brown, A. J., & Setji, T. L. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.941814 · Cited by 1
Nonobese Young Females with Polycystic Ovary Syndrome Have Nutritive Microvascular Dysfunction: A Pilot Study
Leão, L. M. C. S. M., Maranhao, P. A., Oliveira, V. T. L., Villela, N. R., Bordallo, M. A. N., Borges, M. A., Bouskela, E., & Kraemer‐Aguiar, L. G. (2014) · Endocrine Practice · doi:10.4158/ep14130.or · Cited by 1
Fibrillin-3 in the fetal ovary: can it contribute to polycystic ovary syndrome?
Abbott, D. H. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.90 · Cited by 1
The Polycystic Ovarian Syndrome (PCOS)
Magnotti, M., Pessah‐Pollack, R., & Futterweit, W. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2059-4_51 · Cited by 1
Self-citation
Visceral adiposity index correlation with Rotterdam criteria in patients with polycystic ovary syndrome
Aboelnaga, M. M., & Elshahawy, H. A. (2016) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20162623 · Cited by 1
Serological Diagnosis of Helicobacter pylori Infection in Patients With a Polycystic Ovary Syndrome
Kiani, A. H., Asadbeik, E., Bibalan, M. H., Sedighi, M., Eshaghi, M., Gholami, M., & Pournajaf, A. (2015) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.27432 · Cited by 1
CD4+ CD28null in cases of polycystic ovary syndrome
Al-Said, A. A., Al-Shirbiny, M. F. M., & Salama, K. M. (2017) · Benha Medical Journal · doi:10.4103/bmfj.bmfj_70_17 · Cited by 1

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks